Efforts to speed up patients’ access to drugs for very rare diseases are taking shape after the Scottish government launched its new pathway for assessing "ultra-orphan" medicines for severely disabling conditions.
Under the pathway, drugs that meet the new definition of “ultra-orphan medicine” and are initially deemed to be clinically effective,...